期刊文献+

维生素A棕榈酸酯眼用凝胶对抗青光眼药物眼表损伤的防治作用 被引量:9

Vitamin A Palmitate Prevents the Ocular Surface Damage due to Antiglaucomatous Eyedrops
下载PDF
导出
摘要 目的探讨维生素 A 棕榈酸酯眼用凝胶预防临床常用抗青光眼药物眼表损伤的作用。方法正常新西兰大白兔60只采用随机对照方式分为5组,每组12只(12眼)。A 组单纯使用维生素 A 棕榈酸酯眼用凝胶,B 组单纯使用0.5%噻吗洛尔滴眼液,C 组单纯使用0.2%溴莫尼定滴眼液,D 组联合使用维生素 A 棕榈酸酯跟用凝胶及0.5%噻吗洛尔滴眼液,E 组则联合使用维生素 A 棕榈酸酯眼用凝胶及0.2%溴莫尼定滴眼液。用药前及用药1个月后分别进行泪膜破裂时间(tear break-up time,BUT)、基础泪液分泌试验(Schirmertest)及印迹细胞学检查,并通过扫描电镜观察各组角膜上皮形态。结果用药后 B 组及 C 组 BUT 为(11.6±1.9)s 和(10.9±3.1)s,较用药前的(18.6±3.9)s 和(16.5±4.3)s 缩短,并且结膜杯状细胞密度较用药前下降,二者差异有统计学意义(P<0.05)。A,D 及 E 组的BUT及结膜杯状细胞密度用药前后无明显变化。各组用药前后基础泪液分泌的差异均无统计学意义。B 组和 C 组用药后 Nelson 分级标准评为1级;A,D 及 E 组用药后仍为0级。扫描电镜结果表明 B 组及 C 组表现为表面粗糙,细胞失去平整性,卷边、脱落明显增多,细胞间出现裂隙,同时微绒毛密度明显减少。结论长期使用抗青光眼药物可导致兔角膜及结膜结构变化。维生素A棕榈酸酯通过维持泪膜的稳定性及结膜杯状细胞密度,能够有效地减轻临床常用抗青光眼药造成的眼表损伤。(中国眼耳鼻喉科杂志,2007,7:356-358) Purpose To determine whether vitamin A palmitate can prevent the ocular surface damage due to prolonged use of topical antiglaucomatous eyedrops. Methods Sixty eyes of 60 New Zealand white rabbits were randomized to 5 treatment groups with 12 rabbits( 12 eyes) in each group:1% vitamin A palmitate(group A) ,0.5% timolol maleate ( group B), 0. 2% brimonidine ( group C), 1% vitamin A palmitate combined with O. 5 % timolol maleate ( group D), 1% vitamin A palmitate combined with O. 2% brimonidine(group E). Tear break-up times(BUT) and basal Schirmer tests were measured and the conjunctival changes were determined by impression cytology before and one month after the treatment. Corneal damage was evaluated using scanning electron microscopy. Results The BUT of rabbits in groups B and C after the treatment was ( 11.6 ± 1.9) s and ( 10.9 ± 3.1 ) s respectively,which was significantly shorter than ( 18.6 ± 3.9) s and ( 16. 5 ± 4.3) s before the treatment ( P 〈 0. 05 ). There was no significant change in BUT pre-and post-treatment in groups A, D and E. The number of goblet cells in the epithelium after the treatment in groups B and C was significantly lower than before(P 〈0.05 ). The results of basal Schirmer tests had no significant difference between rabbits before and after the treatment in every group. According to Nelson method, specimens of groups B and C were scored to grade 1 while specimens of groups A, D and E remained in grade O. The corneal damage in groups B and C assessed with scanning electron microscopy showed loss of microvilli, increased in the number of epithelial holes, cell peeling, loss of hexagonal shape and retraction of cell borders. Conclusions Prolonged treatment with antiglaucomatous medications in results corneal and conjunctival damage in rabbits ,which could be effectively attenuated by the long-term use of vitamin A palmitate by improving the stability of tear film and increasing the density of goblet cells.
出处 《中国眼耳鼻喉科杂志》 2007年第6期356-358,I0005,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词 抗青光眼药物 角膜 结膜 维生素A Antiglaucoma drugs Cornea Conjunctiva Vitamin A
  • 相关文献

参考文献10

  • 1孙兴怀.青光眼局部降眼压药及其合理应用(下)[J].中国眼耳鼻喉科杂志,2004,4(5):275-278. 被引量:2
  • 2NOECKER R J,HERRYGERS L A,ANWARUDDIN R.Corneal and conjunctival changes caused by commonly used glaucoma medications[J].Cornea,2004,23(5):490-496.
  • 3TURACLI E,BUDAK K,KAUR A,et al.The effects of long-term glaucoma medication on conjunctival impression cytology[J].Int phthalmol,1997,21 (1):27-33.
  • 4DONISI P M,RAMA P,FASOLO A,et al.Analysis of limbal stem cell deficiency by corneal impression cytology[J].Cornea,2003,22(6):533-538.
  • 5YALUAC I S,GEDIKOUGLU G,KARAGOZ Y,et al.Effects of antiglaucoma drugs on ocular surface[J].Acta Ophthalmol Scand,1995,73(3):246-248.
  • 6HERRERAS J M,PASTOR J C,CALONGE M,et al.Ocular surface alteration after long-term treatment with an antiglaucomatous drug[J].Ophthalmology,1992,99(7):1082-1088.
  • 7BECQUET F,GOLDSCHILD M,MOLDOVAN M S,et al.Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface[J].Curr Eye Res,1998,17(4):419-425.
  • 8VDE SAINT JEAN M,BRIGNOLE F,BRINGUIER A F,et al.Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells[J].Invest Ophthalmol Vis Sci,1999,40(3):619-630.
  • 9KOBAYASHI T K,TSUBOTA K,TAKAMIYA E,et al.Effect of retinol palmitate as a treatment for dry eye:a cytological evaluation[J].Ophthalmologica,1997,211 (6):358-361.
  • 10MOJON D,BASCOBOINIK D,HAAS A,et al.Vitamin E inhibits retinal pigment epithelium cell proliferation in vitro[J].Ophthalmic Res,1994,26(5):304-309.

共引文献1

同被引文献133

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部